405 related articles for article (PubMed ID: 29105334)
1. Genetic prognostication in uveal melanoma.
Dogrusöz M; Jager MJ
Acta Ophthalmol; 2018 Jun; 96(4):331-347. PubMed ID: 29105334
[TBL] [Abstract][Full Text] [Related]
2. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
[TBL] [Abstract][Full Text] [Related]
5. [Uveal melanoma: current insights into clinical relevance of genetic testing].
Metz CH; Lohmann D; Zeschnigk M; Bornfeld N
Klin Monbl Augenheilkd; 2013 Jul; 230(7):686-91. PubMed ID: 23877823
[TBL] [Abstract][Full Text] [Related]
6. A review of advanced genetic testing for clinical prognostication in uveal melanoma.
Werdich XQ; Jakobiec FA; Singh AD; Kim IK
Semin Ophthalmol; 2013; 28(5-6):361-71. PubMed ID: 24010756
[TBL] [Abstract][Full Text] [Related]
7. Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.
Versluis M; de Lange MJ; van Pelt SI; Ruivenkamp CA; Kroes WG; Cao J; Jager MJ; Luyten GP; van der Velden PA
PLoS One; 2015; 10(3):e0116371. PubMed ID: 25764247
[TBL] [Abstract][Full Text] [Related]
8. Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
Yavuzyigitoglu S; Mensink HW; Smit KN; Vaarwater J; Verdijk RM; Beverloo B; Brüggenwirth HT; van Marion R; Dubbink HJ; Paridaens D; Naus NC; de Klein A; Kiliç E;
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2232-9. PubMed ID: 27116551
[TBL] [Abstract][Full Text] [Related]
9. Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing.
van Poppelen NM; de Bruyn DP; Bicer T; Verdijk R; Naus N; Mensink H; Paridaens D; de Klein A; Brosens E; Kiliҫ E
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396957
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
[TBL] [Abstract][Full Text] [Related]
11. Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases.
Yavuzyigitoglu S; Koopmans AE; Verdijk RM; Vaarwater J; Eussen B; van Bodegom A; Paridaens D; Kiliç E; de Klein A;
Ophthalmology; 2016 May; 123(5):1118-28. PubMed ID: 26923342
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Value of AJCC Staging in Uveal Melanoma Is Enhanced by Adding Chromosome 3 and 8q Status.
Dogrusöz M; Bagger M; van Duinen SG; Kroes WG; Ruivenkamp CA; Böhringer S; Andersen KK; Luyten GP; Kiilgaard JF; Jager MJ
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):833-842. PubMed ID: 28159971
[TBL] [Abstract][Full Text] [Related]
13. BAP1 germline mutation in two first grade family members with uveal melanoma.
Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
[TBL] [Abstract][Full Text] [Related]
14. The Genetics of Uveal Melanoma: Overview and Clinical Relevance.
Riechardt AI; Kilic E; Joussen AM
Klin Monbl Augenheilkd; 2021 Jul; 238(7):773-780. PubMed ID: 34376007
[TBL] [Abstract][Full Text] [Related]
15. Oncologist-led germline genetic testing for uveal melanoma.
Gillies B; Krema H; Chao A; Lando L; Farncombe KM; Butler M; Altomare F; Kim RH
Ophthalmic Genet; 2023 Jun; 44(3):253-261. PubMed ID: 36974392
[TBL] [Abstract][Full Text] [Related]
16. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.
Martorano LM; Winkelmann RR; Cebulla CM; Abdel-Rahman MH; Campbell SM
Int J Dermatol; 2014 Jun; 53(6):657-63. PubMed ID: 24697775
[TBL] [Abstract][Full Text] [Related]
17. Role of somatic mutations and chromosomal aberrations in the prognosis of uveal melanoma in a Spanish patient cohort.
Silva-Rodríguez P; Bande M; Fernández-Díaz D; Lago-Baameiro N; Pardo M; José Blanco-Teijeiro M; Domínguez F; Loidi L; Piñeiro A
Acta Ophthalmol; 2021 Nov; 99(7):e1077-e1089. PubMed ID: 33421325
[TBL] [Abstract][Full Text] [Related]
18. Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas.
van Engen-van Grunsven AC; Baar MP; Pfundt R; Rijntjes J; Küsters-Vandevelde HV; Delbecq AL; Keunen JE; Klevering JB; Wesseling P; Blokx WA; Groenen PJ
Melanoma Res; 2015 Jun; 25(3):200-9. PubMed ID: 25756553
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in prognostic and predictive testing in uveal melanoma.
Field MG; Harbour JW
Curr Opin Ophthalmol; 2014 May; 25(3):234-9. PubMed ID: 24713608
[TBL] [Abstract][Full Text] [Related]
20. The genetic basis of uveal melanoma.
Nielsen M; Dogrusöz M; Bleeker JC; Kroes WG; van Asperen CA; Marinkovic M; Luyten GP; Jager MJ
J Fr Ophtalmol; 2015 Jun; 38(6):516-21. PubMed ID: 25976137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
